Furthermore, a study has demonstrated the immunosuppressive role of PPARα in cancer, with TDEs containing long-chain fatty acids, increasing lipid content in DCs via PPARα activation, suggesting the potential for DC-based cancer therapy [163]. This evidence concerns the gene PPARA and cancer.